Does TRALOKINUMAB-LDRM Cause Dermatitis atopic? 613 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 613 reports of Dermatitis atopic have been filed in association with TRALOKINUMAB-LDRM. This represents 14.9% of all adverse event reports for TRALOKINUMAB-LDRM.
613
Reports of Dermatitis atopic with TRALOKINUMAB-LDRM
14.9%
of all TRALOKINUMAB-LDRM reports
0
Deaths
12
Hospitalizations
How Dangerous Is Dermatitis atopic From TRALOKINUMAB-LDRM?
Of the 613 reports, 12 (2.0%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Dermatitis atopic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRALOKINUMAB-LDRM. However, 613 reports have been filed with the FAERS database.
What Other Side Effects Does TRALOKINUMAB-LDRM Cause?
Drug ineffective (461)
Pruritus (365)
Rash (266)
Injection site pain (206)
Injection site erythema (136)
Dry skin (135)
Erythema (133)
Eczema (129)
Injection site pruritus (124)
Injection site swelling (119)
What Other Drugs Cause Dermatitis atopic?
DUPILUMAB (33,670)
UPADACITINIB (525)
RUXOLITINIB (211)
TACROLIMUS (200)
CRISABOROLE (134)
NEMOLIZUMAB-ILTO (117)
OMALIZUMAB (111)
ABROCITINIB (110)
PREDNISONE (105)
ADALIMUMAB (103)
Which TRALOKINUMAB-LDRM Alternatives Have Lower Dermatitis atopic Risk?
TRALOKINUMAB-LDRM vs TRAMADOL
TRALOKINUMAB-LDRM vs TRAMADOL\TRAMADOL
TRALOKINUMAB-LDRM vs TRAMETINIB
TRALOKINUMAB-LDRM vs TRAMETINIB DIMETHYL SULFOXIDE
TRALOKINUMAB-LDRM vs TRANDOLAPRIL